Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Harats

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Investigation|March 1, 1995
Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoterD Harats, H Kurihara, P Belloni, et al.
Journal of Lipid Research|December 8, 2000
LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout miceP J Tacken, B Teusink, M C Jong, et al.
Atherosclerosis|July 25, 1998
Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesisJ George, A Afek, B Gilburd, et al.
Clinical Pharmacology and Therapeutics|August 15, 2001
Interindividual variability in sensitivity to warfarin--Nature or nurture?R Loebstein, H Yonath, D Peleg, et al.
Genes & Cancer|June 16, 2012
Antitumor Activity of VB-111, a Novel Antiangiogenic Virotherapeutic, in Thyroid Cancer Xenograft Mouse ModelsH V Reddi, P Madde, Y C Cohen, et al.
Circulation|October 3, 2001
12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient miceJ George, A Afek, A Shaish, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|October 2, 2004
Overexpression of 15-lipoxygenase in the vascular endothelium is associated with increased thymic apoptosis in LDL receptor-deficient miceA Afek, N Zurgil, Y Bar-Dayan, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 5, 1999
Enhancement of atherosclerosis in beta-2-glycoprotein I-immunized apolipoprotein E-deficient miceA Afek, J George, Y Shoenfeld, et al.
Human Antibodies|July 16, 1999
Anti-cardiolipin, anti-endothelial-cell and anti-malondialdehyde-LDL antibodies in uremic patients undergoing hemodialysis: relationship with vascular access thrombosis and thromboembolic eventsJ George, A Aron, Y Levy, et al.
Diabetes, Obesity & Metabolism|January 25, 2003
Rosiglitazone (PPARgamma-agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes-atherosclerosis mouse modelZ Levi, A Shaish, N Yacov, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Investigation|March 1, 1995
Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoterD Harats, H Kurihara, P Belloni, et al.
Journal of Lipid Research|December 8, 2000
LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout miceP J Tacken, B Teusink, M C Jong, et al.
Atherosclerosis|July 25, 1998
Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesisJ George, A Afek, B Gilburd, et al.
Clinical Pharmacology and Therapeutics|August 15, 2001
Interindividual variability in sensitivity to warfarin--Nature or nurture?R Loebstein, H Yonath, D Peleg, et al.
Genes & Cancer|June 16, 2012
Antitumor Activity of VB-111, a Novel Antiangiogenic Virotherapeutic, in Thyroid Cancer Xenograft Mouse ModelsH V Reddi, P Madde, Y C Cohen, et al.
Circulation|October 3, 2001
12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient miceJ George, A Afek, A Shaish, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|October 2, 2004
Overexpression of 15-lipoxygenase in the vascular endothelium is associated with increased thymic apoptosis in LDL receptor-deficient miceA Afek, N Zurgil, Y Bar-Dayan, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 5, 1999
Enhancement of atherosclerosis in beta-2-glycoprotein I-immunized apolipoprotein E-deficient miceA Afek, J George, Y Shoenfeld, et al.
Human Antibodies|July 16, 1999
Anti-cardiolipin, anti-endothelial-cell and anti-malondialdehyde-LDL antibodies in uremic patients undergoing hemodialysis: relationship with vascular access thrombosis and thromboembolic eventsJ George, A Aron, Y Levy, et al.
Diabetes, Obesity & Metabolism|January 25, 2003
Rosiglitazone (PPARgamma-agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes-atherosclerosis mouse modelZ Levi, A Shaish, N Yacov, et al.
Pageof 9